You do not need a script for the whole visit. Start with what you want to understand and keep a note of what still feels unclear.
What concern comes first?
Describe the concern in your own words. Ask what needs to be understood before discussing any treatment. Ask which other choices belong in the conversation.
What did the human research test?
Ask whether the evidence concerns MOTS-c itself, a changed version or measurements of what the body already makes. Ask to see the published results.
As of September 30, 2026, published human treatment results for MOTS-c itself were still missing. A
Keep the kinds of evidence straightWhat exact ingredient is being discussed?
The FDA reviews medicines in the United States. Its review checked September 30, 2026 found different chemical versions offered under the same MOTS-c name. A
Ask for the exact ingredient name. If a product is offered, ask who would make it and where that information is written down.
What rule permits the pharmacy to make this product?
Ask which current rule gives the pharmacy permission to use that exact ingredient. Ask to see the FDA document and have it explained in ordinary words.
Read the dated US positionWhat would I pay if no medicine is offered?
Ask whether the visit fee pays for the assessment regardless of the outcome. Ask about any recurring charge, separate bill and cancellation term. Request the full answer in writing.
Make the payment questions concreteWho answers a later question?
Ask which way to contact the clinician once the visit is over. Ask what a later review would involve and how any new concern would be assessed.
If a word or answer still feels unclear, ask for it in everyday language. Keep the answer beside your original concern.
Carry this with you
Pick the first question to ask, and keep asking for an answer you can understand.
Source notes for this page
The FDA's written MOTS-c review found no published results from treating people with MOTS-c itself. It also found different chemical versions offered under the same name.